Bausch Health Companies vs Zoetis
Bausch Health Companies and Zoetis are similar in size: $10.27bn and $9.47bn of revenue in their latest fiscal years. Bausch Health Companies grew faster (6.7% against 2.3%). Zoetis kept more of each dollar of sales as profit: a net margin of 28.2% against 1.5%.
| Latest fiscal year | Bausch Health CompaniesBHC, 2025 | ZoetisZTS, 2025 |
|---|---|---|
| Revenue | $10.27bn | $9.47bn |
| Revenue growth | 6.7% | 2.3% |
| Net income | $157m | $2.67bn |
| Operating margin | 17.7% | — |
| Net margin | 1.5% | 28.2% |
| Return on equity | — | 65.3% |
| Free cash flow | $1.00bn | $2.28bn |
| Cash | $1.31bn | $2.45bn |
| Total debt | $20.82bn | $9.15bn |
| Debt to equity | — | 267.9% |
| Dividend per share | — | $2.03 |
| Dividend yield | — | 2.6% |
| Share buybacks | — | $3.23bn |
| Employees | 20,300 | — |
| Market value | $3.01bn | $34.37bn |
| Price vs our value range | Below our value range | Within our value range |
| Moat score | 35 (Weak) | 93 (Strong) |
| Insider trades, 12 months | 0 buys, 0 sales | 3 buys, 2 sales |